SCHEMBL23959393

SCHEMBL23959393

CC(C)c1ccc(N2CC[C@H](N)C2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 3/20 0.46
HRH3 Q9Y5N1 2/20 0.46
HTR6 P50406 1/20 0.44
CDK1 P06493 1/20 0.43
CDK4 P11802 1/20 0.43
CCNB1 P14635 1/20 0.43
CCND1 P24385 1/20 0.43
CCNE1 P24864 1/20 0.43
CDK2 P24941 1/20 0.43
NAMPT P43490 1/20 0.43
KHK P50053 1/20 0.42
NOTUM Q6P988 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.39
HPGD P15428 1/20 0.39
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
ALOX15 P16050 1/20 0.38
ALOX12 P18054 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13929499 0.89 HTR6 (0.52) HRH4HRH3HTR6L3MBTL1HPGD
SCHEMBL25016625 0.84 HRH3 (0.45) HRH3HTR6NOTUML3MBTL1HPGD
SCHEMBL25017269 0.84 HRH3 (0.45) HRH3HTR6NOTUML3MBTL1HPGD
SCHEMBL5392075 0.82 MAPT (0.48) HRH4HRH3NAMPTKHKL3MBTL1
SCHEMBL23422579 0.80 KHK (0.48) HRH4HRH3CDK4CCND1NAMPT
Hydrochloric Acid SCHEMBL5383104 0.80 MAPT (0.52) HRH4HRH3NAMPTKHKL3MBTL1
SCHEMBL5692179 0.80 KHK (0.48) HRH4HRH3CDK4CCND1NAMPT
SCHEMBL23422596 0.80 KHK (0.48) HRH4HRH3CDK4CCND1NAMPT
SCHEMBL1534285 0.80 NOTUM (0.56) HRH4NAMPTKHKNOTUMMAPT
SCHEMBL20004338 0.80 HRH3 (0.50) HRH3HTR6L3MBTL1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210332029-A1 ISOINDOLIN-1-ON DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS EFFECTIVE COMPONENT FOR PREVENTING OR TREATING CANCER KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2021-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210332029-A1 ISOINDOLIN-1-ON DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS EFFECTIVE COMPONENT FOR PREVENTING OR TREATING CANCER EGFR, TP53, BRCA1 HRH4 3909/4885HRH3 4541/4885HTR6 1978/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.